Hims operates more like a streamlined prescription service, connecting patients with providers who prescribe based on established protocols
On 1 April 2026, the FDA approved Foundayo (orforglipron) for adults with obesity or overweight with weight-related medical conditions, making it the first small-molecule oral GLP-1 receptor agonist to receive regulatory clearance anywhere in the world
HOW CAN CJC 1295 AND IPAMORELIN HELP
Due to the current heterogeneity of clinical data, future research should focus on adequately powered, well-controlled randomised controlled trials (RCTs) that: incorporate redox biomarker panels and standardised outcomes (pain, FIQR, function, mood/sleep)
While it has a long history of use in Traditional Chinese Medicine (TCM), there is minimal research on its mechanisms and efficacy
What are the disadvantages of L-carnitine